Carbenicillin, cefazolin, and amikacin as an empiric therapy for febrile granulocytopenic cancer patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000188:drug therapy* / Q000209:etiology; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002228:Carbenicillin / Q000627:therapeutic use; D002437:Cefazolin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007239:Infections / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000583:Amikacin; D002228:Carbenicillin; D002437:Cefazolin